Local Anesthetic Volumes for Spinal Anesthesia in Varicose Vein Surgery
4 mg bupivacaine
+ 6 mg bupivacaine
Treatment Study
Summary
Study start date: July 30, 2024
Actual date on which the first participant was enrolled.Varicose veins are enlarged veins that appear as twisted, swollen veins under the skin, typically in the legs and feet. This study focuses on improving anesthesia methods used during surgeries for these veins. It aims to explore how different amounts of spinal anesthetic can affect the surgery experience, especially looking at the level of numbness achieved and how quickly patients can go home after surgery. Since varicose vein surgeries can involve different types of anesthesia, finding the optimal dose for spinal anesthesia may lead to better patient outcomes and quicker recovery times. In this study, participants undergoing surgery for varicose veins will receive spinal anesthesia through an injection into the lower back. Researchers will use different doses of the anesthetic to see how it affects sensation and recovery. The study will monitor the effects during the surgery and the recovery period, assessing the level of numbness and how soon patients can leave the hospital. By comparing these outcomes, the study hopes to identify the best anesthetic dose that ensures patient comfort and efficient recovery.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.80 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 80 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Active ComparatorGroup II
Active ComparatorStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Ankara Etlik City Hospital
Yenimahalle, Turkey (Türkiye)Open Ankara Etlik City Hospital in Google Maps